| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514740000 | Nitrogen containing compound DOAI | 13 |
| 20080242735 | TREATMENT METHOD FOR MMP-IMPLICATED PATHOLOGIES - A treatment method for pathologies in which increased levels of MMP production are implicated in pathogenesis. Examples of such pathologies include pterygium, kerataconus, and macular degeneration. Treatment is based on administration of cysteamine in therapeutically effective amounts. Treatment may be in one of several alternative forms, including eye drops and oral applications. Administration in the form of eye drops may be preferred for pathologies affecting the eyes. | 10-02-2008 |
| 20100173998 | ODOR CONTROLLED PERSONAL CARE COMPOSITIONS CONTAINING HYDROXYPROPYL TRIALKYLAMMONIUM SALTS - A personal care composition is provided which includes from 0.1 to 30% of a dihydroxypropyltri(C | 07-08-2010 |
| 20150105474 | ISOAMYL NITRITE FORMULATIONS - The present invention is directed at isoamyl nitrite formulations suitable for use in medicinal applications. The formulations include a composition of isoamyl nitrite in combination with an epoxidized vegetable oil, identified as stabilized isoamyl nitrite. The isoamyl nitrite may also be combined with petrolatum. Methods of treatment of the formulations are applicable to cyanide poisoning, H | 04-16-2015 |
| 20150105475 | POINT OF USE GENERATION OF AMYL NITRITE - The present disclosure relates to devices and methods for the preparation of amyl nitrite formulations at a point of use location from relatively shelf-stable reagents employing acidic cationic exchange resins. | 04-16-2015 |
| 20150111973 | METHODS OF MODULATING STEROID HORMONE ACTIVITY - The present invention relates to methods of treating steroid hormone related disorders by modulating steroid hormone activity. | 04-23-2015 |
| 514741000 | Benzene ring containing | 3 |
| 20080227869 | Substituted nitrobenzene derivatives as pharmaceutical and other uses thereof - A method for the prophylaxis or treatment of analgesic, hemostatic, antipruritic, antiussive or antiasthmatic action including administrating an effective prophylaxis or treatment amount of at least one compound of Formula I as the active ingredient, pharmaceutical carrier and/or recipient, | 09-18-2008 |
| 20100197804 | PHARMACEUTICAL COMPOSITIONS COMPRISING TERBINAFINE - Pharmaceutical compositions for oral administration comprising terbinafine, a buffering component and a disintegrant. The compositions show rapid disintegration and having taste-masking properties. | 08-05-2010 |
| 20130225694 | COMPOSITIONS AND METHODS OF INHIBITING RETINAL DEGENERATION - Nitrone-based compositions are disclosed that may be utilized for the prevention and treatment of a variety of ophthalmic diseases or conditions where RPE65 protein isomerohydrolase is implicated. Methods of production and use of said nitrone-based compositions, as well as pharmaceutical and ophthalmic compositions containing same, are disclosed. | 08-29-2013 |
| 514742000 | Polynitro | 5 |
| 20090018214 | Composition for Promoting Vascular Smooth Muscle Relaxation - A composition for topical application to a part of the body comprises a local anaesthetic and optionally a vasodilator as active ingredient dissolved in a blend of volatile and non-volatile solvents of different solvating capacities for the active ingredient. The vasodilator may comprise glyceryl trinitrate and the local anaesthetic may comprises an anaesthetic of the aminoamide or aminoester type. The volatile solvent may comprise a mixture of water with a C | 01-15-2009 |
| 20100016446 | STABLE WATER-BASED TOPICAL PHARMACEUTICAL CREAMS AND METHODS OF MAKING AND USING SAME - Disclosed are stable, water-based topical creams comprising nitroglycerin and suitable for pharmaceutical and/or cosmetic use. Also disclosed are methods for preparing the creams. Also disclosed are methods for treating circulatory disorders, methods for preventing or alleviating insufficient circulation, methods for enhancing localized activity of systemically administered drugs, methods for enhancing circulation, and methods for promoting wound healing by administering the disclosed creams. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention. | 01-21-2010 |
| 20100184870 | LONG-TERM STABLE PHARMACEUTICAL PREPARATION CONTAINING THE ACTIVE INGREDIENT GLYCEROL TRINITRATE - A pharmaceutical preparation containing the active substance glyceryl trinitrate having improved storage stability in a container. The improved storage stability is achieved by the addition of a proton-absorbing substance either as part of the preparation as placed into the container or applied to the surface of the preparation's storage container before the remaining components of the preparation are placed into the container. The preparation can preferably be filled into a plastic bottle having a spray pump. | 07-22-2010 |
| 20100216893 | Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate - A pharmaceutical preparation containing the active substance glyceryl trinitrate having improved storage stability in a container. The improved storage stability is achieved by the addition of a proton-absorbing substance either as part of the preparation as placed into the container or applied to the surface of the preparation's storage container before the remaining components of the preparation are placed into the container. The preparation can preferably be filled into a plastic bottle having a spray pump. | 08-26-2010 |
| 20130331461 | Stabilized Granules Containing Glyceryl Trinitrate - Solid pharmaceutical preparation with the active substance glyceryl trinitrate for oromucosal or oral administration characterized in that it contains between 0.05 and 2 weight % glyceryl trinitrate, at least one carrier material, and at least one substance that reduces the volatility of the GTN, whereby this substance is a non-volatile ester stabilizer. | 12-12-2013 |
